NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/29/2023
Back to search
Official data from USPTO
C CLINIQUE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
12/29/2023
Trademark type
Combined
Nice classes
3
Filing date
03/26/2012
Registration date
07/02/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/29/2023
Last transaction
12/29/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/30/1968
First use in commerce
09/30/1968
Drawing code
3
Owner type
16
Owner location
New York, NY
Examiner
BROWN, BARBARA
Law office
M70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a three-dimensional, rectangular shaped clear bottle with rounded edges filled with a yellow colored lotion and a silver cap; on the bottle, the letter "C" appears above the word "CLINIQUE" which is between two horizontal lines, with all wording and lining appearing in black. The broken lines depicting the shape of the cap and bottle indicate placement of the mark on the goods and are not part of the mark.
Holders and representatives
Holders
Clinique Laboratories, LLC
Representatives
Derek Morales The Estee Lauder Companies Inc.
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated skin care preparations
Publications
History of USPTO decisions and trademark events.
38 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/29/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/29/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/29/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
06/30/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/02/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/20/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/20/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/20/2018
E815
TEAS SECTION 8 & 15 RECEIVED
07/09/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2013
PUBO
PUBLISHED FOR OPPOSITION
04/16/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/11/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2013
GNRT
NON-FINAL ACTION E-MAILED
02/22/2013
CNRT
NON-FINAL ACTION WRITTEN
02/22/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/19/2013
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/11/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/30/2013
ALIE
ASSIGNED TO LIE
01/29/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2012
GNRT
NON-FINAL ACTION E-MAILED
07/03/2012
CNRT
NON-FINAL ACTION WRITTEN
07/03/2012
DOCK
ASSIGNED TO EXAMINER
06/26/2012
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/03/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2012
NWAP
NEW APPLICATION ENTERED
03/29/2012
Continuous trademark protection
Get notified about every new filing that threatens C CLINIQUE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.